Development of Extended-Release Formulations Containing Cyclobenzaprine Based on Physiologically Based Biopharmaceutics Modeling and Bioequivalence Safe Space-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of Extended-Release Formulations Containing Cyclobenzaprine Based on Physiologically Based Biopharmaceutics Modeling and Bioequivalence Safe Space

Published:2023-07 Issue: Volume: Page:
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Miranda dos Santos Everton,Ferraz Humberto Gomes,Issa Michele Georges^ORCID,Duque Marcelo Dutra^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference36 articles.

1. Development of extended release mini-tablets containing metoprolol supported by design of experiments and physiologically based biopharmaceutics modeling;Issa;Pharmaceutics,2022

2. Efficient drug development of oseltamivir capsules based on process control, bioequivalence and PBPK modeling;Medeiros;Drug Dev Ind Pharm,2022

3. Justification of drug product dissolution rate and drug substance particle size specifications based on absorption PBPK modeling for lesinurad immediate release tablets;Pepin;Mol Pharmaceut,2016

4. Physiologically based pharmacokinetics modeling in biopharmaceutics: case studies for establishing the bioequivalence safe space for innovator and generic drugs;Wu;Pharm Res,2022

5. In silico prediction of plasma concentrations of fluconazole capsules with different dissolution profiles and bioequivalence study using population simulation;Duque;Pharmaceutics,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP